Patent · US Active

Imatinib immunoassay

US8076097B2 · kind B2 · utility

4Cited by

0References

7Claims

0Family size

Assignee

Saladax Biomedical Inc. · US

Inventors

Salvatore J. Salamone · Stockton, US
Jodi Blake Courtney · Doylestown, US
Alexander Volkov · Sunnyvale, US

Key dates

Filing date	Aug 19, 2009
Grant date	Dec 13, 2011
Priority date	—
Expiry date	Apr 24, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/531
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.